KeyCorp Has Bearish Estimate for ARDT FY2024 Earnings

Ardent Health Partners, LLC (NYSE:ARDT) – Research analysts at KeyCorp cut their FY2024 EPS estimates for Ardent Health Partners in a note issued to investors on Monday, January 6th. KeyCorp analyst M. Gillmor now anticipates that the company will earn $1.20 per share for the year, down from their prior forecast of $1.28. KeyCorp has a “Strong-Buy” rating on the stock. The consensus estimate for Ardent Health Partners’ current full-year earnings is $1.23 per share. KeyCorp also issued estimates for Ardent Health Partners’ Q4 2024 earnings at $0.44 EPS, Q1 2025 earnings at $0.55 EPS, Q2 2025 earnings at $0.54 EPS, Q3 2025 earnings at $0.43 EPS, Q4 2025 earnings at $0.54 EPS, FY2025 earnings at $2.05 EPS and FY2026 earnings at $2.27 EPS.

Several other research firms have also weighed in on ARDT. Leerink Partners lifted their price target on Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a research report on Tuesday, November 12th. Bank of America downgraded shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $22.00 to $19.00 in a research report on Wednesday, November 6th. Truist Financial lowered their price target on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a research report on Monday. JPMorgan Chase & Co. restated a “neutral” rating and issued a $20.00 price objective on shares of Ardent Health Partners in a report on Tuesday, December 17th. Finally, Stephens reiterated an “overweight” rating and set a $24.00 target price on shares of Ardent Health Partners in a report on Thursday, September 19th. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $22.00.

Ardent Health Partners Trading Up 0.3 %

ARDT stock opened at $16.41 on Thursday. Ardent Health Partners has a fifty-two week low of $14.57 and a fifty-two week high of $20.72. The stock’s 50 day moving average price is $16.66. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78.

Institutional Trading of Ardent Health Partners

Several institutional investors have recently added to or reduced their stakes in ARDT. Oliver Luxxe Assets LLC bought a new position in shares of Ardent Health Partners during the fourth quarter valued at $1,465,000. JPMorgan Chase & Co. purchased a new position in Ardent Health Partners in the 3rd quarter worth about $154,000. Franklin Resources Inc. bought a new position in Ardent Health Partners during the 3rd quarter valued at about $15,839,000. Barclays PLC purchased a new stake in shares of Ardent Health Partners during the 3rd quarter valued at about $385,000. Finally, Geode Capital Management LLC bought a new stake in shares of Ardent Health Partners in the third quarter worth approximately $2,581,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.